206 results
Page 3 of 11
8-K
kxntve
14 Apr 21
Amendments to Articles of Incorporation or Bylaws
11:07am
8-K
EX-3.1
a6cg eqdssbzkfq5
14 Apr 21
Amendments to Articles of Incorporation or Bylaws
11:07am
8-K
EX-99.1
1yp55mak8rxs1j
25 Feb 21
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:04pm
8-K
EX-99.1
x2p 1qabysogflvdpd
3 Feb 21
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
8:36am
424B5
r9bf4toy0k6
13 Oct 20
Prospectus supplement for primary offering
5:27pm
S-3ASR
EX-4.2
1din314 196m
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
hynu5
8 Jul 20
Automatic shelf registration
8:50am
S-8
EX-10.1
5m4b7bc
7 Jul 20
Registration of securities for employees
4:20pm
8-K
EX-4.1
hlxoqjy73u6t3
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm